Fresenius Kabi Oncology Ltd. | FKONCO | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
| Chart | 2012 | 2013 | |
|---|---|---|---|
Revenue |
| 5,266 | 5,963 |
Cost of revenue |
| -2,172 | -1,650 |
Gross Profit |
| 3,094 | 4,313 |
Sales, general & ad... |
| -2,435 | -2,883 |
Depreciation |
| -240 | -258 |
Provision |
| 0 | 0 |
Other op inc/exp... |
| 0 | 0 |
Operating income |
| 420 | 1,172 |
Interest expense |
| -177 | 26 |
Other income/exp... |
| 474 | -50 |
Profit before tax |
| 717 | 1,148 |
Income tax & other ta... |
| 207 | 342 |
Net income from c... |
| 510 | 806 |
Extraordinary & disc... |
| 0 | 0 |
Share of associates |
| 0 | 0 |
Minority Interest |
| 0 | 0 |
Net Income |
| 510 | 806 |
NI - Preferred Di... |
| 510 | 806 |
Basic shares |
| 158 | 158 |
Diluted Shares |
| 158 | 158 |
EPS Basic |
| 3.22 | 5.09 |
EPS Diluted |
| 3.22 | 5.09 |